There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

California's luxury real estate market tells a fascinating story of wealth, migration, and changing lifestyles. Between 2018 ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

Discover how PomDoctor Limited aims to revolutionize China's telehealth industry with a $15M IPO, despite facing stiff ...

AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.

Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...

New breed of artificial intelligence startups will draw acquirers and IPO interest, venture investors predict.

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

While 2021 saw a flurry of high-profile IPOs like Zomato, Paytm, and Nykaa, the last couple of years have been more cautious ...

The Draft Red Herring Prospectus (DRHP) from Allchem Lifescience Limited to raise up to Rs 190 Cr through an initial public ...

The Hong Kong University of Science and Technology (HKUST) and Shanghai Industrial Investment (Holdings) Co., Ltd. (SIIC) together announced the ...